跳至主要内容
临床试验/CTRI/2022/06/043421
CTRI/2022/06/043421尚未招募不适用

A Randomized Open Label Controlled Clinical Study To Evaluate The Efficacy Of Vyaghriharitaki Avaleha In The Management Of Vataja Kasa With Special Reference To Pulmonary Eosinophilia

Dr Manjushri P1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年6月27日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Reduction In Signs And Symptoms Of Vataja Kasa like Shushka Kasa Prasakta Vega Shirashoola Parshwa Shoola Hrit Shoola Swara Bheda Kshamanana

研究概览

简要总结

THIS CLINICAL TRIAL IS PUT FORWARD TO EVALUATE THE EFFICACY OF VYAGHRIHARITAKI AVALEHA IN THE MANAGEMENT OF VATAJA KASA WITH SPECIAL REFERENCE TO PULMONARY EOSINOPHILIA

HYPOTHESIS

1 NULL HYPOTHESIS

H0: THE EFFICACY OF VYAGHRIHARITAKI AVALEHA IS EQUIVALENT TO VIDANGADI CHURNA IN THE MANAGEMENT OF VATAJA KASA WITH SPECIAL REFERENCE TO PULMONARY EOSINOPHILIA

2 ALTERNATIVE HYPOTHESIS

H1: THE EFFICACY OF VYAGHRIHARITAKI AVALEHA IS DIFFERENT THAN VIDANGADI CHURNA IN THE MANAGEMENT OF VATAJA KASA WITH SPECIAL REFERENCE TO PULMONARY EOSINOPHILIA

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
Open Label

入排标准

年龄范围
21.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • 1 Subjects Having Shushka Kasa With Three Or More Classical Signs And Symptoms Of Vataja Kasa With Special Reference To Pulmonary Eosinophilia 2 Absolute Eosinophilic Count From 500 Cells Per Cu mm to 2500 Cells Per Cu mm 3 Subjects Willing To Participate With Written Informed Consent.

排除标准

  • 1 Subjects Diagnosed With Other Respiratory Diseases Like Pulmonary Tuberculosis Bronchial Asthma Pneumonia Pleurisy Ca Bronchus Emphysema And Complicated Covid-19 Cases 2 Uncontrolled Systemic Illness Like Diabetes Mellitus Type1 Type 2 And Hypertension 3 Pregnant And Lactating Women 4 Any Other Systemic Illness Interfering The Course Of Treatment.

结局指标

主要结局

Reduction In Signs And Symptoms Of Vataja Kasa like Shushka Kasa Prasakta Vega Shirashoola Parshwa Shoola Hrit Shoola Swara Bheda Kshamanana

时间窗: 15th Day during the Trial Period | 30th Day Post Trial Period | 45th Day After Follow up Period of Trial

次要结局

  • Reduction In Levels Of Absolute Eosinophilic Count(30th Day 45th Day)

研究者

发起方
Dr Manjushri P
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验